Delving into the Latest Updates on Allogenic adipose derived mesenchymal stem cells(Aarhus University Hospital) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms

AD-MSC(Aarhus University Hospital)

Target-

Mechanism

Stem cell replacements

Therapeutic Areas

Immune System DiseasesSkin and Musculoskeletal Diseases

Active Indication

Osteoarthritis, Knee

Inactive Indication-

Originator Organization

Århus Universitetshospital

Active Organization

Århus Universitetshospital

Inactive Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

This phase I and II double blinded randomized clinical controlled trial investigates the safety and efficacy of intraarticular knee injection with allogenic adipose derived mesenchymal stem cells (AD-MSC), in patients suffering from mild-moderate knee osteoarthritis compared to placebo injection with saline.

Start Date07 Mar 2024

Sponsor / Collaborator

Århus Universitetshospital

NCT01678534 / CompletedPhase 2IIT

Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue. Safety Assessment. A Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial.(AMASCIS-01/2011)

Phase IIa clinical trial, pilot, single centre, prospective, randomized, double-blind, placebo-controlled, with sequential inclusion of patients

Start Date01 Sep 2014

Sponsor / Collaborator-

100 Clinical Results associated with Allogenic adipose derived mesenchymal stem cells(Aarhus University Hospital)

Login to view more data

100 Translational Medicine associated with Allogenic adipose derived mesenchymal stem cells(Aarhus University Hospital)

Login to view more data

100 Patents (Medical) associated with Allogenic adipose derived mesenchymal stem cells(Aarhus University Hospital)

Login to view more data

100 Deals associated with Allogenic adipose derived mesenchymal stem cells(Aarhus University Hospital)

Login to view more data